Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janice Smith

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Cancer Research|December 29, 2011
N-Myc regulates expression of the detoxifying enzyme glutathione transferase GSTP1, a marker of poor outcome in neuroblastomaJamie I Fletcher, Samuele Gherardi, Jayne Murray, et al.
Molecular Autism|June 11, 2022
Large multicenter randomized trials in autism: key insights gained from the balovaptan clinical development programSuma Jacob, Evdokia Anagnostou, Eric Hollander, et al.
JAMA Neurology|November 18, 2024
Amyloid-Related Imaging Abnormalities (ARIA) in Clinical Trials of Gantenerumab in Early Alzheimer DiseaseStephen Salloway, Jakub Wojtowicz, Nicola Voyle, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentJanice Smith, Catherine J Mummery, Jeffrey L Cummings, et al.
Journal of Alzheimer'S Disease : JAD|December 17, 2024
Long-term safety of gantenerumab in participants with Alzheimer's disease: A phase III, open-label extension study (SCarlet RoAD)Mercè Boada, Anuja Neve, Bibha Das, et al.
Eclinicalmedicine|October 21, 2024
Promoting diversity in clinical trials: insights from planning the ALUMNI AD study in historically underrepresented US populations with early symptomatic Alzheimer's diseaseAlexandria Wise-Brown, Sharon A Brangman, J Neil Henderson, et al.
European Journal of Cancer (Oxford, England : 1990)|April 24, 2007
Cell lines from MYCN transgenic murine tumours reflect the molecular and biological characteristics of human neuroblastomaAndy J Cheng, Ngan Ching Cheng, Jette Ford, et al.
Cancer Research|August 6, 2009
Small-molecule multidrug resistance-associated protein 1 inhibitor reversan increases the therapeutic index of chemotherapy in mouse models of neuroblastomaCatherine A Burkhart, Fujiko Watt, Jayne Murray, et al.
Clinical Chemistry|January 3, 2025
Detection of Clinically Relevant Monogenic Copy-Number Variants by a Comprehensive Genome-Wide Microarray with Exonic CoverageMatthew Hoi Kin Chau, Stephanie A Anderson, Rodger Song, et al.
American Journal of Respiratory Cell and Molecular Biology|December 29, 2023
Homozygous, Intragenic Tandem Duplication of <i>SFTPB</i> Causes Neonatal Respiratory FailureJennifer A Wambach, Daniel J Wegner, Joseph Kitzmiller, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Cancer Research|December 29, 2011
N-Myc regulates expression of the detoxifying enzyme glutathione transferase GSTP1, a marker of poor outcome in neuroblastomaJamie I Fletcher, Samuele Gherardi, Jayne Murray, et al.
Molecular Autism|June 11, 2022
Large multicenter randomized trials in autism: key insights gained from the balovaptan clinical development programSuma Jacob, Evdokia Anagnostou, Eric Hollander, et al.
JAMA Neurology|November 18, 2024
Amyloid-Related Imaging Abnormalities (ARIA) in Clinical Trials of Gantenerumab in Early Alzheimer DiseaseStephen Salloway, Jakub Wojtowicz, Nicola Voyle, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentJanice Smith, Catherine J Mummery, Jeffrey L Cummings, et al.
Journal of Alzheimer'S Disease : JAD|December 17, 2024
Long-term safety of gantenerumab in participants with Alzheimer's disease: A phase III, open-label extension study (SCarlet RoAD)Mercè Boada, Anuja Neve, Bibha Das, et al.
Eclinicalmedicine|October 21, 2024
Promoting diversity in clinical trials: insights from planning the ALUMNI AD study in historically underrepresented US populations with early symptomatic Alzheimer's diseaseAlexandria Wise-Brown, Sharon A Brangman, J Neil Henderson, et al.
European Journal of Cancer (Oxford, England : 1990)|April 24, 2007
Cell lines from MYCN transgenic murine tumours reflect the molecular and biological characteristics of human neuroblastomaAndy J Cheng, Ngan Ching Cheng, Jette Ford, et al.
Cancer Research|August 6, 2009
Small-molecule multidrug resistance-associated protein 1 inhibitor reversan increases the therapeutic index of chemotherapy in mouse models of neuroblastomaCatherine A Burkhart, Fujiko Watt, Jayne Murray, et al.
Clinical Chemistry|January 3, 2025
Detection of Clinically Relevant Monogenic Copy-Number Variants by a Comprehensive Genome-Wide Microarray with Exonic CoverageMatthew Hoi Kin Chau, Stephanie A Anderson, Rodger Song, et al.
American Journal of Respiratory Cell and Molecular Biology|December 29, 2023
Homozygous, Intragenic Tandem Duplication of <i>SFTPB</i> Causes Neonatal Respiratory FailureJennifer A Wambach, Daniel J Wegner, Joseph Kitzmiller, et al.
Pageof 6